The relationship between cognition and functioning in schizophrenia: A semi-systematic review by Kharawala, Saifuddin, Hastedt, Claudia, Podhorna, Jana, Shukla, Hemlata, Kappelhoff, Bregt, Harvey, Philip D.

Get full text

Budget and health impact of switching eligible patients with atrial fibrillation to lower- dose dabigatran by Fens, Tanja, de Jong, Lisa, Kappelhoff, Bregt, Boersma, Cornelis, Postma, Maarten J.

Get full text

Simple and rapid method for the simultaneous determination of the non-nucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma using liquid chromatograp... by Kappelhoff, Bregt S, Rosing, Hilde, Huitema, Alwin D.R, Beijnen, Jos H

Get full text

Are adverse events of nevirapine and efavirenz related to plasma concentrations? by KAPPELHOFF, Bregt S, VAN LETH, Frank, BEIJNEN, Jos H, HUITEMA, Alwin D. R, ROBINSON, Patrick A, MACGREGOR, Thomas R, BARALDI, Ezio, MONTELLA, Francesco, UIP, David E, THOMPSON, Melanie A, RUSSELL, Darren B, LANGE, Joep M. A

Get full text

Practical guidelines to interpret plasma concentrations of antiretroviral drugs by KAPPELHOFF, Bregt S, CROMMENTUYN, Kristel M. L, DE MAAT, Manique M. R, MULDER, Jan W, HUITEMA, Alwin D. R, BEIJNEN, Jos H

Get full text

Nevirapine and efavirenz pharmacokinetics and covariate analysis in the 2NN study by KAPPELHOFF, Bregt S, VAN LETH, Frank, MACGREGOR, Thomas R, LANGE, Joep M. A, BEIJNEN, Jos H, HUITEMA, Alwin D. R

Get full text

Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals by KAPPELHOFF, Bregt S, HUITEMA, Alwin D. R, YALVAC, Zeynep, PRINS, Jan M, MULDER, Jan W, MEENHORST, Pieter L, BEIJNEN, Jos H

Get full text

Development and validation of a population pharmacokinetic model for ritonavir used as a booster or as an antiviral agent in HIV‐1‐infected patients by Kappelhoff, Bregt S., Huitema, Alwin D. R., Crommentuyn, Kristel M. L., Mulder, Jan W., Meenhorst, Pieter L., Van Gorp, Eric C. M., Mairuhu, Albert T. A., Beijnen, Jos H.

Get full text

Cost-effectiveness of tipranavir versus comparator protease inhibitor regimens in HIV infected patients previously exposed to antiretroviral therapy in the Netherlands by Hubben, Gijs A A, Bos, Jasper M, Veltman-Starkenburg, Christa A, Stegmeijer, Simon, Finnern, Henrik W, Kappelhoff, Bregt S, Simpson, Kit N, Tramarin, Andrea, Postma, Maarten J

Get full text

Population pharmacokinetics of indinavir alone and in combination with ritonavir in HIV‐1‐infected patients by Kappelhoff, Bregt S., Huitema, Alwin D. R., Sankatsing, Sanjay U. C., Meenhorst, Pieter L., Van Gorp, Eric C. M., Mulder, Jan W., Prins, Jan M., Beijnen, Jos H.

Get full text

Should non-nucleoside reverse transcriptase inhibitors be combined? by Kappelhoff, Bregt S, Huitema, Alwin D R, Beijnen, Jos H

Get full text

Administration Advantages and Cost-Savings with Dabigatran Etexilate Versus Parenteral Agents for Thromboprophylaxis After Major Orthopaedic Surgery in the Netherlands by Boersma, Cornelis, Kappelhoff, Bregt S, Postma, Maarten J

Get full text

The authors' reply by Kappelhoff, Bregt S, Huitema, Alwin D. R, Beijnen, Jos H

Get full text

The authors' reply by Kappelhoff, Bregt S, Huitema, Alwin D. R, Beijnen, Jos H

Get full text

Practical Guidelines to Interpret Plasma Concentrations of Antiretroviral Drugs: The Authors??? Reply by Kappelhoff, Bregt S, Huitema, Alwin D R, Beijnen, Jos H

Get full text

Practical guidelines to interpret plasma concentrations of antiretroviral drugs by Leith, Jonathan, Hinzmann, Ralf, Mayers, Douglas

Get full text